Cargando…

Complement C1 Esterase Inhibitor Levels Linked to Infections and Contaminated Heparin-Associated Adverse Events

Activation of kinin-kallikrein and complement pathways by oversulfated-chondroitin-sulfate (OSCS) has been linked with recent heparin-associated adverse clinical events. Given the fact that the majority of patients who received contaminated heparin did not experience an adverse event, it is of parti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Zhao-Hua, Chen, Trina, Arora, Kamalpreet, Hyams, Kenneth, Kozlowski, Steven
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3325920/ https://www.ncbi.nlm.nih.gov/pubmed/22514695 http://dx.doi.org/10.1371/journal.pone.0034978

Ejemplares similares

Oversulfated Chondroitin Sulfate Inhibits the Complement Classical Pathway by Potentiating C1 Inhibitor
por: Zhou, Zhao-Hua, et al.
Publicado: (2012)

No prominent role for complement C1-esterase inhibitor in Marfan syndrome mice
por: Hibender, Stijntje, et al.
Publicado: (2022)

THE REQUIREMENT OF SERINE ESTERASE FUNCTION IN COMPLEMENT-DEPENDENT ERYTHROPHAGOCYTOSIS
por: Pearlman, David S., et al.
Publicado: (1969)

SOME PROPERTIES OF AN ESTERASE DERIVED FROM PREPARATIONS OF THE FIRST COMPONENT OF COMPLEMENT
por: Ratnoff, Oscar D., et al.
Publicado: (1957)

The Use of Plasma-Derived Complement C1-Esterase Inhibitor Concentrate (Berinert®) in the Treatment of Angiotensin Converting Enzyme-Inhibitor Related Angioedema
por: Hermanrud, Thorbjørn, et al.
Publicado: (2016)

C'1 ESTERASE EFFECT ON ACTIVITY AND PHYSICOCHEMICAL PROPERTIES OF THE FOURTH COMPONENT OF COMPLEMENT
por: Müller-Eberhard, Hans J., et al.
Publicado: (1965)

Nebulized C1-Esterase Inhibitor does not Reduce Pulmonary Complement Activation in Rats with Severe Streptococcus Pneumoniae Pneumonia
por: de Beer, Friso, et al.
Publicado: (2016)

Effect of complement C1-esterase inhibitor on brain edema and inflammation after mild traumatic brain injury in an animal model
por: Weiss, Eric, et al.
Publicado: (2020)

C1 esterase inhibitor in pediatric cardiac surgery with cardiopulmonary bypass plays a vital role in activation of the complement system
por: Miyamoto, Takashi, et al.
Publicado: (2019)

Nebulized Cl-esterase inhibitor treatment does not attenuate pulmonary complement activation in a rat model of severe Streptococcus pneumoniae pneumonia
por: De Beer, FM, et al.
Publicado: (2014)

PARTIAL BIOCHEMICAL CHARACTERIZATION OF THE ACTIVATED ESTERASE REQUIRED IN THE COMPLEMENT-DEPENDENT CHEMOTAXIS OF RABBIT POLYMORPHONUCLEAR LEUKOCYTES
por: Becker, Elmer L., et al.
Publicado: (1967)

COMPLEMENT AS A MEDIATOR OF INFLAMMATION : ENHANCEMENT OF VASCULAR PERMEABILITY BY PURIFIED HUMAN C'1 ESTERASE
por: Ratnoff, Oscar D., et al.
Publicado: (1963)

Pseudohyperphosphatemia due to contamination with heparin: A case for caution
por: Senthilkumaran, S., et al.
Publicado: (2014)

The Lectin Pathway of Complement in Myocardial Ischemia/Reperfusion Injury—Review of Its Significance and the Potential Impact of Therapeutic Interference by C1 Esterase Inhibitor
por: Panagiotou, Anneza, et al.
Publicado: (2018)

THE INHIBITION OF PLASMIN, PLASMA KALLIKREIN, PLASMA PERMEABILITY FACTOR, AND THE C'1r SUBCOMPONENT OF THE FIRST COMPONENT OF COMPLEMENT BY SERUM C'1 ESTERASE INHIBITOR
por: Ratnoff, Oscar D., et al.
Publicado: (1969)

Recombinant Human C1 Esterase Inhibitor for the Management of Adverse Events Related to Intravenous Immunoglobulin Infusion in Patients With Common Variable Immunodeficiency or Polyneuropathy: A Pilot Open-Label Study
por: Melamed, Isaac R., et al.
Publicado: (2021)

THE SECOND COMPONENT OF HUMAN COMPLEMENT: ITS ISOLATION, FRAGMENTATION BY C'1 ESTERASE, AND INCORPORATION INTO C'3 CONVERTASE
por: Polley, Margaret J., et al.
Publicado: (1968)

Improving total saccharification yield of Arabidopsis plants by vessel-specific complementation of caffeoyl shikimate esterase (cse) mutants
por: Vargas, Lívia, et al.
Publicado: (2016)

Dilemma in Diagnosis of Pyogenic Meningitis in Cerebrospinal Fluid Contaminated with Blood: Does Leucocyte Esterase Test Help?
por: Krishnamurthy, Vani, et al.
Publicado: (2019)

Identification and immobilization of a novel cold-adapted esterase, and its potential for bioremediation of pyrethroid-contaminated vegetables
por: Fan, Xinjiong, et al.
Publicado: (2017)

Human Complement Regulators C4b-Binding Protein and C1 Esterase Inhibitor Interact with a Novel Outer Surface Protein of Borrelia recurrentis
por: Grosskinsky, Sonja, et al.
Publicado: (2010)

Bleeding and Thrombotic Adverse Events in Hospitalized Patients Under Empiric Treatment for Suspected Heparin-Induced Thrombocytopenia While Awaiting Confirmatory Testing
por: Dykes, Kaitlyn C., et al.
Publicado: (2021)

Comparison of net adverse clinical events between bivalirudin and heparin as anticoagulants for percutaneous coronary intervention in Chinese patients
por: Chai, Lina, et al.
Publicado: (2023)

Crude Heparin Preparations Unveil the Presence of Structurally Diverse Oversulfated Contaminants
por: Mendes, Aline, et al.
Publicado: (2019)

The perioperative course of C1-esterase-inhibitor: evidence for an early deficiency
por: Cobas Meyer, M, et al.
Publicado: (1999)

Recombinant Human C1 Esterase Inhibitor in the Management of Hereditary Angioedema
por: Riedl, Marc
Publicado: (2015)

The Role of C1-Esterase Inhibitors in the Management of Vasogenic Edema in Glioblastoma
por: Naro, Gillian R., et al.
Publicado: (2020)

Quantification of human C1 esterase inhibitor protein using an automated turbidimetric immunoassay
por: Tange, Clare E., et al.
Publicado: (2018)

Erratum: Antihistone Properties of C1 Esterase Inhibitor Protect against Lung Injury
por: Wygrecka, Malgorzata, et al.
Publicado: (2022)

Complement receptor is an inhibitor of the complement cascade
Publicado: (1981)

Ocular adverse events with immune checkpoint inhibitors
por: Fang, Tony, et al.
Publicado: (2019)

Mucocutaneous adverse events to immune checkpoint inhibitors
por: Muhaj, Fiorinda, et al.
Publicado: (2023)

Unexpected Adverse Events of Immune Checkpoint Inhibitors
por: Shalata, Walid, et al.
Publicado: (2023)

Heparin: Major bleeding event: case report
Publicado: (2021)

Molecular Interactions between Complement Factor H and Its Heparin and Heparan Sulfate Ligands
por: Perkins, Stephen J., et al.
Publicado: (2014)

Non-Anticoagulant Heparins as Heparanase Inhibitors
por: Cassinelli, Giuseppe, et al.
Publicado: (2020)

A “turn on” fluorescent probe for heparin and its oversulfated chondroitin sulfate contaminant
por: Ding, Yubin, et al.
Publicado: (2015)

Serum C1-esterase inhibitor, an essential and independent prognosticator of gastric carcinoma.
por: Janssen, C. W., et al.
Publicado: (1989)

Organophosphate acetylcholine esterase inhibitor poisoning from a home-made shampoo
por: Sadaka, Yair, et al.
Publicado: (2011)

Comparison of persistence rates of acetylcholine-esterase inhibitors in a state Medicaid program
por: Abughosh, Susan M, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_slu1s1amcnhlflhao8v6o8khjc